Stefańczyk, S.A.; Hayn, C.; Heitmann, J.; Jung, S.; Zekri, L.; Märklin, M.
Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia. Cancers 2024, 16, 2455.
https://doi.org/10.3390/cancers16132455
AMA Style
Stefańczyk SA, Hayn C, Heitmann J, Jung S, Zekri L, Märklin M.
Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia. Cancers. 2024; 16(13):2455.
https://doi.org/10.3390/cancers16132455
Chicago/Turabian Style
Stefańczyk, Sylwia A., Clara Hayn, Jonas Heitmann, Susanne Jung, Latifa Zekri, and Melanie Märklin.
2024. "Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia" Cancers 16, no. 13: 2455.
https://doi.org/10.3390/cancers16132455
APA Style
Stefańczyk, S. A., Hayn, C., Heitmann, J., Jung, S., Zekri, L., & Märklin, M.
(2024). Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia. Cancers, 16(13), 2455.
https://doi.org/10.3390/cancers16132455